This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Immunomodulating and neuroprotective properties of...
Clinical trial

Immunomodulating and neuroprotective properties of autologous multipotent mesenchymal stem cells in patients with multiple sclerosis - A randomised placebo-controlled double-blinded phase II study

Read time: 1 mins
Last updated:21st Jun 2012
To assess the effect of intra-venously applied autologous MSCs on cerebral inflammation in multiple sclerosis patients
Category Value
Study start date 2012-06-21

View full details